Literature DB >> 17493417

Statin wars: emphasis on potency vs event reduction and safety?

Carl J Lavie, Richard V Milani, James H O'Keefe.   

Abstract

Mesh:

Substances:

Year:  2007        PMID: 17493417     DOI: 10.4065/82.5.539

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


× No keyword cloud information.
  5 in total

1.  To B or not to B: is non-high-density lipoprotein cholesterol an adequate surrogate for apolipoprotein B?

Authors:  Carl J Lavie; Richard V Milani; James H O'Keefe
Journal:  Mayo Clin Proc       Date:  2010-05       Impact factor: 7.616

2.  Treatment of refractory angina.

Authors:  Mark A Grise; Anil Verma
Journal:  Ochsner J       Date:  2009

Review 3.  Physical activity, cardiorespiratory fitness, and exercise training in primary and secondary coronary prevention.

Authors:  Damon L Swift; Carl J Lavie; Neil M Johannsen; Ross Arena; Conrad P Earnest; James H O'Keefe; Richard V Milani; Steven N Blair; Timothy S Church
Journal:  Circ J       Date:  2013-01-18       Impact factor: 2.993

Review 4.  Secondary prevention of coronary heart disease in elderly patients following myocardial infarction: are all HMG-CoA reductase inhibitors alike?

Authors:  Bijesh P Maroo; Carl J Lavie; Richard V Milani
Journal:  Drugs Aging       Date:  2008       Impact factor: 3.923

Review 5.  Impact of ezetimibe on atherosclerosis: is the jury still out?

Authors:  Firas J Al Badarin; Iftikhar J Kullo; Stephen L Kopecky; Randal J Thomas
Journal:  Mayo Clin Proc       Date:  2009-04       Impact factor: 7.616

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.